Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection

A P Menday1

  • 1Leo Pharmaceuticals, Princes Risborough, Bucks, UK. paul.menday@leo-pharma.com

Insights

A 3-day course of pivmecillinam effectively treats uncomplicated urinary tract infections, showing comparable results to a 7-day cephalexin regimen. This short-course antibiotic therapy is well-tolerated and a viable option for acute cystitis.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Urology

Background:

  • Urinary tract infections (UTIs) are common, often caused by Escherichia coli.
  • Short-course antibiotic regimens are desirable to improve patient compliance and reduce side effects.
  • Pivmecillinam is an antibiotic effective against common UTI pathogens.

Purpose of the Study:

  • To compare the clinical and bacteriological efficacy of a 3-day pivmecillinam course versus a 7-day cephalexin course for acute, uncomplicated UTIs.
  • To assess the tolerability of both treatment regimens.

Main Methods:

  • A randomized clinical trial involving 216 patients with bacteriologically confirmed UTIs.
  • Patients received either pivmecillinam (200 mg TID for 3 days) or cephalexin (250 mg QID for 7 days).
  • Clinical and bacteriological outcomes, including Escherichia coli eradication, were evaluated.

Main Results:

  • Clinical cure/improvement rates were high for both groups: 95.3% for pivmecillinam and 93.6% for cephalexin.
  • Bacteriological success rates were 89.7% for pivmecillinam and 81.7% for cephalexin.
  • Escherichia coli eradication rates were 90.1% for pivmecillinam and 80.6% for cephalexin. Both treatments were well tolerated.

Conclusions:

  • A 3-day course of pivmecillinam is clinically and bacteriologically effective for uncomplicated cystitis.
  • Pivmecillinam offers a well-tolerated, shorter treatment option compared to standard cephalexin regimens.
  • Short-course pivmecillinam demonstrates high efficacy, particularly against Escherichia coli, in treating acute UTIs.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...